| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 8, 2024 | SUPN Supernus Pharmaceuticals, Inc. | Hudson Frederick M. | Director | Sell | 8,722 | $36.28 | $316,434.16 | -23.5% | +6.1% | +25.7% | |
| Nov 8, 2024 | GTBIF Green Thumb Industries Inc. | Georgiadis Anthony | President | Sell | 1,138 | $9.26 | $10,539.70 | -5.4% | - | - | |
| Nov 8, 2024 | SUPN Supernus Pharmaceuticals, Inc. | Gemayel Georges | Director | Sell | 10,787 | $36.30 | $391,568.10 | -44.8% | +6.1% | +25.7% | |
| Nov 8, 2024 | LNTH Lantheus Holdings, Inc. | Heino Mary Anne50 | Director | Sell | 11,487 | $87.16 | $1,001,217.84 | -0.6% | +3.9% | -41.6% | |
| Nov 8, 2024 | LLY Eli Lilly & Co | Zakrowski Donald A | SVP, Finance, &CAO | Sell | 900 | $803.38 | $723,042.00 | -14.1% | +4.7% | +11.2% | |
| Nov 8, 2024 | TCNNF Trulieve Cannabis Corp. | Zhang Marie | Chief Operating Officer | Buy | 21,300 | $7.19 | $153,147.00 | +56.8% | - | - | |
| Nov 7, 2024 | SUPN Supernus Pharmaceuticals, Inc. | Gemayel Georges | Director | Sell | 14,213 | $36.62 | $520,480.06 | -51.6% | +8.5% | +26.4% | |
| Nov 7, 2024 | SUPN Supernus Pharmaceuticals, Inc. | Mottola Frank | SVP, Quality, Gmp, Ops, It | Sell | 15,000 | $36.98 | $554,700.00 | -64.7% | +8.5% | +26.4% | |
| Nov 7, 2024 | SUPN Supernus Pharmaceuticals, Inc. | Khattar Jack A.64 | President, CEO | Sell | 125,000 | $36.68 | $4,585,000.00 | -11.9% | +8.5% | +26.4% | |
| Nov 7, 2024 | UTHR United Therapeutics Corp | Benkowitz Michael47 | President And COO | Sell | 25,000 | $398.85 | $9,971,214.12 | -37.1% | -12.0% | +11.5% | |
| Nov 6, 2024 | AMPH Amphastar Pharmaceuticals, Inc. | Peters William J52 | CFO, EVP &Treasurer | Sell | 7,426 | $52.05 | $386,523.30 | -7.3% | -37.8% | -54.6% | |
| Nov 6, 2024 | AMPH Amphastar Pharmaceuticals, Inc. | Liawatidewi Yakob47 | EVP Corp Admin Center | Sell | 5,214 | $52.05 | $271,388.70 | -6.5% | -37.8% | -54.6% | |
| Nov 6, 2024 | ALKS Alkermes Plc. | Hopkinson Craig C.54 | EVP R&D, Chief Medical Officer | Sell | 10,471 | $29.53 | $309,168.84 | -9.5% | +6.9% | +8.2% | |
| Nov 6, 2024 | KNSA Kiniksa Pharmaceuticals International, Plc | Patel Sanj K | Chairman &CEO | Sell | 89,561 | $23.00 | $2,059,903.00 | -53.0% | -18.6% | +67.7% | |
| Nov 6, 2024 | HIMS Hims & Hers Health, Inc. | Carroll Patrick Harrison52 | Chief Medical Officer | Sell | 15,000 | $22.07 | $331,093.50 | -7.1% | +78.7% | +77.3% | |
| Nov 5, 2024 | HIMS Hims & Hers Health, Inc. | Chi Michael | Chief Commercial Officer | Sell | 2,054 | $22.00 | $45,188.00 | -1.0% | +88.6% | +111.9% | |
| Nov 5, 2024 | HIMS Hims & Hers Health, Inc. | Dudum Andrew47 | Chief Executive Officer | Sell | 333,332 | $20.76 | $6,921,163.62 | -14.6% | +88.6% | +111.9% | |
| Nov 5, 2024 | UTHR United Therapeutics Corp | Giltner Richard | Director | Sell | 10,000 | $381.70 | $3,817,022.00 | -21.6% | -7.4% | +16.9% | |
| Nov 4, 2024 | BMY Bristol Myers Squibb Co | Holzer Phil M | SVP And Controller | Sell | 700 | $55.62 | $38,930.50 | -5.6% | +8.1% | -17.8% | |
| Nov 4, 2024 | UTHR United Therapeutics Corp | Edgemond James | CFO And Treasurer | Sell | 7,778 | $374.02 | $2,909,127.56 | -20.1% | -5.9% | +16.1% | |
| Nov 1, 2024 | UTHR United Therapeutics Corp | Benkowitz Michael47 | President And COO | Sell | 14,700 | $374.46 | $5,504,605.09 | -22.3% | -5.8% | +19.1% | |
| Nov 1, 2024 | BMY Bristol Myers Squibb Co | Hirawat Samit53 | EVP,Chief Med.offr.,Drug Dev. | Buy | 1,830 | $54.68 | $100,055.25 | +3.0% | +8.9% | -15.2% | |
| Nov 1, 2024 | UTHR United Therapeutics Corp | Causey Christopher59 | Director | Sell | 510 | $376.63 | $192,080.33 | -12.2% | -5.8% | +19.1% | |
| Nov 1, 2024 | ETST Earth Science Tech, Inc. | Cazeau Jeff P. H. | Independent Director | Buy | 71,091 | $0.14 | $9,952.74 | +71.8% | - | - | |
| Oct 31, 2024 | SCLX Scilex Holding Co | Ji Henry | Executive Chairperson | Buy | 8,888 | $0.94 | $8,351.16 | +2.9% | -53.1% | -50.9% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.